2.要約四半期連結財務諸表及び主な注記
(1)要約四半期連結損益計算書及び要約四半期連結包括利益計算書
(要約四半期連結損益計算書)
| | |
| | (単位:百万円) |
| 前第1四半期連結累計期間 (自 2020年4月1日 至 2020年6月30日) | 当第1四半期連結累計期間 (自 2021年4月1日 至 2021年6月30日) |
売上収益 | 71,402 | 68,965 |
売上原価 | △11,488 | △12,331 |
売上総利益 | 59,913 | 56,634 |
販売費及び一般管理費 | △20,866 | △21,750 |
研究開発費 | △12,166 | △14,729 |
製品に係る無形資産償却費 | △808 | △818 |
その他の収益 | 3,039 | 1,282 |
その他の費用 | △536 | △1,824 |
営業利益 | 28,575 | 18,794 |
金融収益 | 4,894 | 4,229 |
金融費用 | △447 | △82 |
税引前四半期利益 | 33,022 | 22,941 |
法人所得税費用 | △8,524 | 9,256 |
四半期利益 | 24,497 | 32,198 |
| | |
四半期利益の帰属 | | |
親会社の所有者 | 24,495 | 32,238 |
非支配持分 | 2 | △40 |
四半期利益 | 24,497 | 32,198 |
| | |
1株当たり四半期利益 | | |
基本的1株当たり四半期利益(円) | 80.62 | 106.94 |
希薄化後1株当たり四半期利益(円) | 80.58 | 106.91 |
E0092345070塩野義製薬株式会社Shionogi & Co., Ltd.四半期第3号参考様式 [IFRS](連結)IFRStrueCTE2021-04-012021-06-30Q12022-03-312020-04-012020-06-302021-03-311falsefalsefalse450702021-06-30jpigp_cor:NonControllingInterestsIFRSMember450702021-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702021-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember450702021-06-30jpigp_cor:RetainedEarningsIFRSMember450702021-06-30jpigp_cor:TreasurySharesIFRSMember450702021-06-30jpigp_cor:CapitalSurplusIFRSMember450702021-06-30jpigp_cor:ShareCapitalIFRSMember450702021-04-012021-06-30jpigp_cor:NonControllingInterestsIFRSMember450702021-04-012021-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702021-04-012021-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember450702021-04-012021-06-30jpigp_cor:RetainedEarningsIFRSMember450702021-04-012021-06-30jpigp_cor:TreasurySharesIFRSMember450702021-04-012021-06-30jpigp_cor:CapitalSurplusIFRSMember450702021-04-012021-06-30jpigp_cor:ShareCapitalIFRSMember450702021-03-31jpigp_cor:NonControllingInterestsIFRSMember450702021-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702021-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450702021-03-31jpigp_cor:RetainedEarningsIFRSMember450702021-03-31jpigp_cor:TreasurySharesIFRSMember450702021-03-31jpigp_cor:CapitalSurplusIFRSMember450702021-03-31jpigp_cor:ShareCapitalIFRSMember450702020-06-30jpigp_cor:NonControllingInterestsIFRSMember450702020-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702020-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember450702020-06-30jpigp_cor:RetainedEarningsIFRSMember450702020-06-30jpigp_cor:TreasurySharesIFRSMember450702020-06-30jpigp_cor:CapitalSurplusIFRSMember450702020-06-30jpigp_cor:ShareCapitalIFRSMember450702020-04-012020-06-30jpigp_cor:NonControllingInterestsIFRSMember450702020-04-012020-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702020-04-012020-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember450702020-04-012020-06-30jpigp_cor:RetainedEarningsIFRSMember450702020-04-012020-06-30jpigp_cor:TreasurySharesIFRSMember450702020-04-012020-06-30jpigp_cor:CapitalSurplusIFRSMember450702020-04-012020-06-30jpigp_cor:ShareCapitalIFRSMember450702020-03-31jpigp_cor:NonControllingInterestsIFRSMember450702020-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702020-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450702020-03-31jpigp_cor:RetainedEarningsIFRSMember450702020-03-31jpigp_cor:TreasurySharesIFRSMember450702020-03-31jpigp_cor:CapitalSurplusIFRSMember450702020-03-31jpigp_cor:ShareCapitalIFRSMember450702021-08-02450702020-03-31450702021-03-31450702020-04-012020-06-30450702020-06-30450702021-04-012021-06-30450702021-06-30iso4217:JPYxbrli:sharesxbrli:pureiso4217:JPY